Retevmo

FDA Approves Selpercatinib for Pediatric Patients With RET-Altered Metastatic Thyroid Cancer, Solid Tumors
Oncology Nursing News
Wed, 05/29/24 - 09:41 pm
Eli Lilly
FDA
Retevmo
pediatrics
thyroid cancer
Lilly’s Retevmo Shows Superior Survival in Phase III Thyroid Cancer Trial
BioSpace
Wed, 08/23/23 - 10:12 am
Eli Lilly
Retevmo
thyroid cancer
medullary thyroid cancer
clinical trials
Exelixis
Capometyx
Sanofi
Caprelsa
Eli Lilly meets primary endpoint in LIBRETTO-431 study for NSCLC
Clinical Trials Arena
Mon, 08/7/23 - 10:25 am
Eli Lilly
clinical trials
Retevmo
non-small cell lung cancer
Keytruda
Lilly’s Retevmo receives FDA approval to treat solid tumours
Pharmaceutical Business Review
Thu, 09/22/22 - 10:13 am
Eli Lilly
FDA
Retevmo
solid tumors
metastatic solid tumors
Lilly gene-targeted drug shows potential for use across cancers
BioPharma Dive
Sun, 04/11/21 - 11:51 pm
Eli Lilly
AAACR
Retevmo
cancer
clinical trials
3 Blockbuster Drug Launches to Watch This Year
Motley Fool
Sun, 01/24/21 - 03:24 pm
drug launches
GSK
Cabenuva
HIV
ViiV
Gilead Sciences
Trodelvy
Eli Lilly
Retevmo
cancer
Roche, Blueprint raise pressure on Lilly with new Gavreto approval
Pharmaforum
Wed, 12/2/20 - 10:33 am
Roche
Blueprint Medicines
Gavreto
thyroid cancer
Retevmo
Eli Lilly
FDA approval tracker: several early decisions in May
EP Vantage
Wed, 06/3/20 - 10:24 am
FDA
Deciphera
Qinlock
Blueprint Medicines
Ayvakit
Eli Lilly
Retevmo
Bristol-Myers Squibb
Opdivo
Yervoy
A groundbreaking cancer drug nabs fast OK, giving Eli Lilly boasting rights as a rival speeds close behind
Endpoints
Sun, 05/10/20 - 09:30 pm
Eli Lilly
selpercatinib
Retevmo
FDA
cancer
Loxo Oncology
Blueprint Medicines